October 8, 2020
New Pancreatic Cancer Treatment May Add Years to the Lives of Those Facing Death BookmarkGeorge Lundberg, MD
Article from the Miami Herald curated by Contributing Editor George Lundberg, MD, who notes:
The RenovoCath chemotherapy device permits targeted delivery of usual chemotherapy drugs directly into, and limited to, localized but inoperable pancreatic cancers. It is currently being tested in a phase 3 clinical trial.